PROF Profound Medical Corp.
6.910USD+21.65%Mkt Cap: 252.44M $P/E: —Today
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The compa…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap252.44M USD
Enterprise Value191.23M USD
Revenue (TTM)19.09M USD
Gross Profit11.39M USD
Net Income (TTM)-42.57M USD
Revenue/Share0.57 USD
Last Price6.910 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees162
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.34
PEG—
EV/EBITDA-5.48
EV/Revenue10.02
P/S11.64
P/B4.46
EPS (TTM)-0.99
EPS (Forward)-0.59
52W Range
4.80051% of range8.950
52W High8.950 USD
52W Low4.800 USD
Profitability
Gross Margin70.77%
Oper. Margin-445.67%
EBITDA Margin-182.74%
Profit Margin-264.44%
ROE-64.08%
ROA-54.95%
Growth
Revenue Growth12.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-38.21M USD
CapEx (TTM)242.00K USD
FCF Margin-130.04%
FCF Yield-9.83%
Net Debt-30.89M USD
Net Debt/EBITDA0.89
Balance Sheet
Debt/Equity0.07
Current Ratio6.46
Quick Ratio5.25
Book Value/Sh1.36 USD
Cash/Share1.05 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateOct 16, 2019
Analyst Consensus
Rating—
Target (Mean)11.14 USD
Upside (mean)+61.2%
Target Range10.00 USD – 12.00 USD
10.00+61.2% to mean12.00
# Analysts5
Ownership
Shares Out.36.53M
Float35.50M
Insiders4.09%
Institutions44.98%
Short Interest
Short Ratio12.9d
Short % Float4.87%
Short % Out.4.30%
Shares Short1.57M
Short (prev mo.)1.84M
Technical
SMA 506.650 (+3.9%)
SMA 2006.830 (+1.2%)
Beta0.56
S&P 52W Chg15.78%
Avg Vol (30d)221.36K
Avg Vol (10d)121.50K
Technical Indicators
RSI (14)61.5
MACD-0.1358
MACD Signal-0.2454
MACD Hist.+0.1096
BB Upper6.762 USD
BB Middle5.985 USD
BB Lower5.209 USD
BB Width25.94%
ATR (14)0.4073 USD
Vol Ratio (20d)19.93x